Written by Dr. Diane Mueller
You’re feeling exhausted all the time, your joints ache for no apparent reason, and your doctor has recommended a Western blot test, a vital diagnostic tool for detecting Lyme disease, although it is frequently misunderstood. Numerous patients find the outcomes puzzling, resulting in a surplus of inquiries and minimal clarity. This test highlights identifying markers for the Lyme disease organism; however, understanding its meaning and significance requires an understanding of the test itself, its accuracy, and what the test results imply about your health.
If you’re wondering ‘which is the best test?’, head on over to our Best Lyme Disease Test guide.
Western blot testing has significant limitations, with an accuracy rate of only 62-80%. The test misses 40-50% of actual Lyme disease cases due to timing issues, immune suppression, and the testing of only specific bacterial strains, resulting in false negatives that are extremely common.
Early-stage infections and chronic cases are most likely to test negative for the disease. Antibodies need weeks to develop after an initial infection, while long-term Lyme disease can suppress immune responses, making antibody detection nearly impossible in both scenarios.
Alternative testing methods and specialty labs offer better detection rates. Expanded Western blot panels, PCR testing, and labs that test for multiple Borrelia species can catch infections missed by standard CDC protocols, thereby improving diagnostic accuracy to 75-90%.
Clinical symptoms and exposure history are more important than test results. Given the high false-negative rate, experienced practitioners focus on symptom patterns, tick exposure history, and response to treatment rather than relying solely on laboratory results.
We have helped thousands of people in Colorado, Wyoming, New Jersey, Pennsylvania, Texas, Wisconsin restore their health and quality of life by diagnosing and treating their Lyme Disease.
Here’s the uncomfortable truth: conventional Lyme testing is inaccurate about 40-50% of the time. You might walk out of your doctor’s office with a “negative” result while Lyme bacteria are still throwing a party in your system.
The two-step Lyme disease test (ELISA followed by Western blot) was designed for tracking, not diagnosis, and often fails because it relies on sufficient antibody production, which may not occur quickly or at all in some individuals.
The Western blot detects antibodies to 10 different Lyme proteins; however, it can yield a false negative result because only positive results that meet strict criteria are acknowledged. Those criteria say that to call a test positive, it must show at least 5 IgG bands or 2 IgM bands.
Yet, doctors all too often take the bait and haul off to misinterpret results, thinking no positive result = no Lyme. And, they do this even when patterns of bands that are supposed to look like a negative result are something Lyme patients with lots of symptoms might see as a positive. Consult a more reliable doctor for Western blot results.
You’ve probably heard about the Western blot test if you’re exploring the murky waters of Lyme disease diagnosis. It’s supposed to be the gold standard—but here’s the thing: even gold can tarnish.
Think of the Western blot as a blood test that tells you nothing on its own but reveals a crucial secret when combined with other data. It works best when used in conjunction with the ELISA. If your immune system has fought off Borrelia, the bacteria that cause Lyme disease, it has left numerous clues behind in the blood. These clues come in the form of antibodies, and the Western blot is designed to find them.
Here’s where it gets tricky: The test detects antibodies against Borrelia burgdorferi by identifying up to 10 different types of bacteria in your blood. According to the Centers for Disease Control and Prevention criteria, you must have certain types of antibodies to test positive. You must demonstrate the presence of a certain number of these antibodies in your blood, stained with a certain number of colors, to show that your body had a certain number of encounters with the bacteria; otherwise, you didn’t have Lyme disease.
The antibodies being looked for come in two types: IgM, which is the antibody you make first when you have an infection (sort of like the fresh tracks you make in the snow when you walk around outside), and IgG, which is the antibody that appears later (like the tracks you make during a blizzard that are now covered with a fresh layer of snow). Even in the best laboratories, with ideal conditions, the Western blot is only approximately 80% accurate.
Scientists use a method known as gel electrophoresis to separate Borrelia proteins based on their size. These proteins are then put onto a special kind of membrane. When added serum is mixed with the protein, if there are antibodies to the bacterium in the serum, they will bind to the matching proteins. This is like making a direct imprint of the proteins with the antibodies in the serum.
The proteins and antibodies form very visible structures that appear as abnormally dark rectangles or bands when viewed under UV light.
The Western blot process unfolds like a carefully choreographed dance:
Protein separation kicks things off through electrophoresis—imagine proteins racing through a gel maze, with smaller ones zipping ahead while larger ones lumber behind.
Transfer moves these separated proteins onto a membrane, creating a protein map that’s ready for testing.
Incubation introduces your serum to this protein world, giving any Lyme antibodies in your blood a chance to find their bacterial matches.
Detection reveals the antibody-protein pairs as visible bands—your immune system’s testimony written in dark lines.
Interpretation applies CDC-established criteria to these band patterns; however, human judgment (and sometimes bias) enters the picture here.
Additionally, factors such as shipping temperature can impact test accuracy. Your sample might tell a different story depending on whether it stayed cool during its journey to the lab.
We have helped thousands of people in Colorado, Wyoming, New Jersey, Pennsylvania, Texas, Wisconsin restore their health and quality of life by diagnosing and treating their Lyme Disease.
While the Western blot might seem like the gold standard, three critical weaknesses in conventional Lyme testing can leave you struggling for answers when you need them most.
The ELISA test, required before conducting the Western blot for Lyme disease, often yields false negatives, approximately 50% of the time. This two-step system has a low accuracy, missing nearly half of the actual Lyme cases. If ELISA results are negative, most doctors stop testing, leaving patients without answers while they continue to feel unwell. Many never get to take the more accurate Western blot test because ELISA incorrectly excludes them.
Standard tests are falling short in detecting Lyme disease. Most tests only check for one bacterial strain, Borrelia burgdorferi B31, ignoring other Borrelia species that can also cause Lyme symptoms.
This means you could have apparent Lyme symptoms, a history of tick exposure, and live in a high-risk area, but still test negative if your infection is from a different strain. The tests aren’t wrong—they just don’t cover all possibilities, leaving many cases undiagnosed.
The criteria established by the CDC for interpreting Western blot tests were created to track Lyme disease, not for diagnosing it. Yet, these criteria are used by doctors to determine which treatments to administer to patients. Two important Lyme disease-specific bands, 39 and 34, are often overlooked because they aren’t part of the required five-band combination that must be present to yield a positive test result.
Complicated results stem from testing issues, such as inconsistent antigen expression and weak antibody responses in chronic cases. Many physicians have not received adequate training in interpreting these test patterns and rely instead on outdated CDC guidelines, which can too easily dismiss obvious signs of Lyme disease.
Interpreting your Western blot results doesn’t have to feel like reading ancient hieroglyphics. You are looking at bands that represent specific proteins of the Lyme bacteria—your immune system’s protein “mug shots” of the Lyme bacteria. These bands can provide valuable insights into the Lyme bacteria and your immune system’s response to them.
Understanding which bands matter most can completely change how you interpret your results. At the same time, the CDC focuses on quantity (how many bands), while competent practitioners pay attention to quality, specifically which bands light up.
Band (kDa) | Protein Type | Clinical Significance | Why It Matters |
|---|---|---|---|
18 | Unknown | IgG panel | Standard CDC requirement |
23-25 | OspC | Highly specific for Lyme | Early infection marker—if this shows up, pay attention |
28 | Outer membrane | IgG panel | Standard CDC requirement |
30 | Unknown | IgG panel | Standard CDC requirement |
31 | OspA | Highly sensitive | Shows up in many Lyme cases, but some vaccines can cause this |
34 | OspB | Extremely specific | Not even in the CDC criteria, but many specialists consider it a “smoking gun” |
39 | BmpA | Highly specific | Strong indicator of active infection |
41 | Flagellin | Very sensitive | Common in Lyme, but other bacteria have similar proteins |
45 | Unknown | IgG panel | Standard CDC requirement |
58 | FliY | IgG panel | Standard CDC requirement |
66 | Unknown | IgG panel | Standard CDC requirement |
83-93 | Various | Highly specific | Late-stage infection markers—often missed by standard testing |
Here’s what many doctors won’t tell you: bands 31, 34, 39, and 83-93 are like finding fingerprints at a crime scene. They’re highly specific to Lyme disease. Yet the CDC criteria completely ignore band 34, one of the most reliable indicators.
Band 41 is trickier. It shows up in about 80% of Lyme cases (making it highly sensitive), but it’s also found in other bacterial infections. Think of it as circumstantial evidence—helpful when combined with other clues, but not definitive on its own.
The CDC’s interpretation system feels like it was designed by committee in the early 1990s—because it was. Their criteria require either 2 out of 3 specific IgM bands OR 5 out of 10 IgG bands to call your test “positive.“
IgM antibodies appear first, usually within the first few weeks of infection. Think of them as your immune system’s rapid response team. The CDC only considers IgM results valid within the first 4 weeks of illness, as they claim that false positives become common after that.
But here’s the catch—many Lyme-literate practitioners see persistent IgM responses in chronic cases, suggesting ongoing infection rather than false positives.
IgG antibodies develop later and stick around longer. They’re like your immune system’s long-term memory. A positive IgG typically indicates either past exposure to or ongoing infection with the antigen.
The frustrating reality? The CDC model treats all bands equally, ignoring that some are far more specific than others. So, practitioners use what’s called “Lyme-specific band interpretation“—focusing on those particular bands (23-25, 31, 34, 39, 83-93) even if the overall CDC criteria aren’t met. This approach catches cases that traditional interpretation misses.
Your test might show bands 31, 34, and 39—three of the most Lyme-specific markers available—but still be labeled “negative” because it doesn’t meet the threshold of 5 total bands. That’s why finding a practitioner who understands these nuances can make all the difference in getting the correct diagnosis.
We have helped thousands of people in Colorado, Wyoming, New Jersey, Pennsylvania, Texas, Wisconsin restore their health and quality of life by diagnosing and treating their Lyme Disease.
Your immune system might be playing hide-and-seek. The Western blot test’s mean sensitivity hovers around 62.4%, which means it misses nearly 4 out of 10 cases, not exactly reassuring when trying to obtain an accurate diagnosis.
Your body needs time to mount a proper immune response against Borrelia bacteria. Think of it like training an army — you can’t expect your soldiers (antibodies) to be fully equipped and ready for battle within days of the invasion.
Early-stage Lyme disease often produces false negatives because your immune system hasn’t had enough time to create detectable antibody levels. Those telltale protein bands the test looks for? They might be too faint to register, even though the bacteria are setting up camp in your body.
Most Western blot tests only screen for Borrelia burgdorferi B31 strain — but that’s like only checking for one type of flu when multiple strains are circulating.
Borrelia mayonii and other species can cause identical Lyme symptoms yet slip right past standard testing. You could have textbook Lyme disease from a different bacterial cousin, but your test comes back clean because the lab wasn’t looking for the right culprit.
Laboratory-grown bacteria don’t always express the same proteins they would in your body. It’s like studying a wolf in captivity versus observing one in the wild — the behaviors (and in this case, protein expressions) can be dramatically different.
Cultured bacteria lysates used in testing may lack certain antigens that would trigger your specific antibodies. Your immune system created excellent antibodies against the real infection, but the test antigens don’t match up properly.
Long-term Lyme infections can suppress your immune system’s ability to produce antibodies. It’s a cruel irony — the longer you’ve been sick, the harder it becomes to prove you’re sick using antibody-based tests.
Chronic Lyme patients often exhibit weakened antibody responses because the bacteria have developed mechanisms to evade immune detection. Your body’s defense system becomes worn down, much like a security guard who has been working double shifts for months.
New testing methods improve Lyme disease diagnosis. Traditional Western blots miss many cases, but advanced tests now detect what older methods overlook.
Specialty labs offer expanded panels, testing for multiple Borrelia species like B. burgdorferi, B. afzelii, B. garinii, and B. mayonii, for more accurate results.
Some doctors use alternative criteria, focusing on Lyme-specific bands (23, 31, 34, 39, 93) as key indicators, even if they don’t meet CDC guidelines. Symptoms with these bands are often considered clinically significant by Lyme experts.
PCR testing can directly detect bacterial DNA, rather than waiting for your immune system to produce antibodies. This method works exceptionally well in early infection when antibody levels are still too low to detect. Think of it as finding the actual burglar, rather than just looking for fingerprints.
C6 peptide ELISA tests offer improved sensitivity compared to traditional ELISAs, detecting more cases in the early stages of disease progression. These tests use synthetic peptides that more closely mimic the proteins your immune system encounters during infection.
T-cell response assays measure cellular immunity rather than just antibodies. Your T-cells remember infections even when antibody levels decline, making this approach valuable for chronic cases where traditional tests are ineffective.
Comprehensive panel tests for co-infections are performed simultaneously. Babesia, Bartonella, Ehrlichia, and Anaplasma often travel with Lyme disease, creating complex symptom patterns that single-pathogen tests miss entirely.
Advanced practitioners combine multiple testing methods for the most accurate picture. They might run a Western blot alongside PCR testing and co-infection panels, then interpret results within your clinical context.
Some doctors use provocation testing, where you take antimicrobial herbs for several days before testing. This can temporarily increase bacterial load and antibody production, making infections more detectable.
Testing Method | Sensitivity | Best Used For | Typical Cost |
|---|---|---|---|
Standard Western Blot | ~62% | Confirmation after ELISA | $150-300 |
Expanded Western Blot | ~75-80% | Multiple Borrelia species | $400-600 |
PCR Testing | ~70-85% | Early infection detection | $200-400 |
T-cell Response | ~80-90% | Chronic or treated cases | $300-500 |
International labs sometimes use different criteria that catch cases missed by U.S. standards. European interpretation guidelines recognize different band patterns and lower thresholds for positive results.
Direct antigen detection methods look for bacterial proteins rather than your immune response. These newer techniques can identify active infections even when your immune system isn’t producing detectable antibodies.
The path to accurate Lyme diagnosis requires more than blind faith in outdated testing protocols. Your health deserves better than a 50% chance of misdiagnosis and years of unexplained suffering.
Remember, negative test results don’t automatically mean you’re healthy. The Western blot’s limitations are real and significant, particularly when symptoms persist despite negative results. It’s time to dig deeper with advanced testing methods and Lyme-literate practitioners.
Reading Western blot results at home isn’t recommended—and honestly, it’s like trying to perform surgery with a butter knife. The bands on your report represent specific antibody reactions; however, interpreting them requires an understanding of cross-reactivity patterns and the clinical context in which they occur. Even experienced doctors sometimes disagree on borderline results.
ELISA works like a smoke detector—it’ll catch most fires but might go off when you burn toast. It measures total antibody levels in your blood. Western blot acts like a forensic investigator, separating individual proteins and showing exactly which Lyme-specific antibodies you’re producing. It’s 100% specific when done at quality labs.
Most labs deliver Western blot results within 3-5 business days, though some specialty labs take up to 2 weeks. Rushing your results won’t change them, but choosing the right lab absolutely will
IgM antibodies show up first (like your body’s emergency response team), typically within 2-4 weeks of infection. IgG antibodies arrive later (the long-term security detail), usually 6-8 weeks after the bite. You may test positive for one, both, or neither, depending on the timing of the test.
Retesting depends on your situation. If you’re symptomatic with negative results, retest in 4-6 weeks. Post-treatment, many doctors recommend retesting at 3-month intervals to monitor antibody levels, as they may not disappear even after successful treatment.
The two-step process involves an initial ELISA (enzyme-linked immunosorbent assay) screening test, followed by a confirmatory Western blot test. This approach is recommended because ELISA alone can produce up to 66% false negatives in early Lyme disease, creating a “diagnostic dead zone“ where patients may be misdiagnosed and left untreated.
Bands 31 and 34 are key indicators of Lyme disease, along with bands 23, 39, and 93. These specific bands indicate the presence of antibodies against Borrelia burgdorferi proteins. Band 41 can appear in various infections, so it’s less specific and should be interpreted carefully in conjunction with other bands.
IgM antibodies typically appear first during an acute infection (within weeks), while IgG antibodies develop later and can persist for a long time. IgM positivity may indicate a recent infection, while IgG positivity suggests either a current infection or past exposure. Both should be evaluated together for accurate diagnosis.
Waddell, L., Greig, J., Mascarenhas, M., Harding, S., Lindsay, R., & Ogden, N. (2016). The Accuracy of Diagnostic Tests for Lyme Disease in Humans, A Systematic Review and Meta-Analysis of North American Research. PLoS ONE, 11. https://doi.org/10.1371/journal.pone.0168613.
Kuhn, M., & Bransfield, R. (2014). Divergent opinions of proper Lyme disease diagnosis and implications for children co-morbid with autism spectrum disorder.. Medical hypotheses, 83 3, 321-5. https://doi.org/10.1016/j.mehy.2014.06.005.
Salińska, A., Węgrzyn, P., Węgrzyn, K., Góra, A., Wasilewski, M., Nowicki, M., Skwara, J., Barański, D., Dąbrowska, N., & Laskowski, G. (2024). Lyme borreliosis – review of the diagnosis and management in the multidisciplinary tick-borne disease. Medical Science. https://doi.org/10.54905/disssi.v28i150.e93ms3399.
We have helped thousands of
people restore their health
and quality of life by diagnosing
and treating their Lyme Disease.
“Dr. Mueller’s approach to medicine is refreshing! There is only so much you can do with western medicine and in my life I was needing a new approach. By addressing the whole body, nutritional diet factors, environmental factors, blood work, and incorporating ideas I had not previously known, I was able to break through with my conditions. I am not only experiencing less pain in my life, but through the process of healing guided by Dr. Diane Mueller, I am now happy to say I have more consciousness surrounding how I eat, what to eat and when things are appropriate. Living by example Dr. Mueller has a vibrancy that makes you want to learn and know more about your body and overall health. I highly recommend her to anyone looking for new answers, a new approach to health, or in need of freedom from pain and limitations.”
-Storie S.
Kihei, HI
